Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
Apply
Pembrolizumab & 177Lu-PSMA-617
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step